J. L. Bainbridge & Co. Inc. bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 1,845 shares of the company’s stock, valued at approximately $286,000. Other institutional investors and hedge funds also […]